Related Experiment Video
Updated: Jun 6, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNAs and other small silencing RNAs in cancer
Carlos Rovira1, Maria C Güida, Alfonso Cayota
1Department of Oncology, Lund University, Lund, Sweden.
Abstract:
Small noncoding RNAs are key controllers of cellular function, and their deregulation can lead to cancer development and metastatic evolution. This review summarizes the most important examples of small RNAs involved in human cancer and discusses their clinical use as biomarkers and drug targets for diagnosis, prognosis, and treatment of cancer. We also describe the possible mechanisms underlying small RNA-mediated transformation and outline the future describing new small RNA families with great potential in cancer biology.
Insights
Small noncoding RNAs regulate cell function and are implicated in cancer. This review covers their role in human cancers, clinical applications as biomarkers and drug targets, and future potential in cancer biology.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Small noncoding RNAs are crucial regulators of cellular processes.
- Their dysregulation is linked to cancer development and metastasis.
- Understanding these molecules is vital for cancer research.
Purpose of the Study:
- To review the role of small noncoding RNAs in human cancers.
- To discuss their clinical utility as biomarkers and therapeutic targets.
- To explore future directions in small RNA-mediated cancer biology.
Main Methods:
- Literature review of small noncoding RNAs in cancer.
- Analysis of clinical applications for diagnosis, prognosis, and treatment.
- Discussion of underlying mechanisms and emerging small RNA families.
Main Results:
- Identified key small RNA examples involved in human cancer.
- Highlighted their potential as biomarkers for cancer detection and prognosis.
- Discussed their role as drug targets for cancer therapy.
Conclusions:
- Small noncoding RNAs are significant players in human cancer.
- They offer promising avenues for clinical applications in oncology.
- Further research into novel small RNA families will advance cancer biology and treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

